Meet MYOCURE partner Asphalion at upcoming events

MYOCURE partner Asphalion kicked off this conference season with attending a number of high-profile events over the recent weeks.

From September 28-30, an Asphalion team attended the trade fair BIOSPAIN 2016. BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.300) and companies participating (+850). Throughout the event, Asphalion was present at booth F42-43. In addition, MYOCURE partners Lidia Cánovas and Marta Rayo Lunar further addressed regulatory issues in a press conference held at the event on September 28.

At the same time in Brussels, Asphalion team member Anna Graupera attended the Innovative Medicines Initiative Stakeholder Forum from September 28-29 to learn about and discuss IMI's latest activities and plans.

As an international Drug Development and Regulatory Affairs Consultancy, Asphalion brings science to the market through regulation compliance. Within MYOCURE, Asphalion is responsible for supporting the consortium with regulatory issues towards developing an effective and safe innovative gene therapy platform to cure MTM and GSDII. Asphalion’s active participation at relevant events ensures remaining up-to-date and in contact with relevant stakeholders at all times.

Further conferences are already registered for the upcoming months.

Find out where to meet Asphalion here.

MYOCURE partner Asphalion at a press conference during the BIOSPAIN 2016